Menu
GeneBe

ABCG5

ATP binding cassette subfamily G member 5, the group of ATP binding cassette subfamily G

Basic information

Region (hg38): 2:43812471-43838865

Links

ENSG00000138075NCBI:64240OMIM:605459HGNC:13886Uniprot:Q9H222AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • sitosterolemia 1 (Definitive), mode of inheritance: AR
  • sitosterolemia (Supportive), mode of inheritance: AR
  • sitosterolemia 1 (Strong), mode of inheritance: AR
  • sitosterolemia 1 (Definitive), mode of inheritance: AR
  • sitosterolemia (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Sitosterolemia 2ARBiochemical; CardiovascularIn some individuals, medical (eg, with bile acid resins/lipid-lowering agents) and dietary (eg, with cholesterol and plant fat restriction) treatment may be beneficial for some parameters, and may, along with preventive measures related to cardiovascular manifestations, reduce morbidity and mortalityBiochemical; Cardiovascular; Hematologic11099417; 11138003; 12840092; 16029460; 16472606; 17018391; 17785700; 17976197; 19111681; 20521169; 20543520; 20719861; 21576934; 24166850; 31901240

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ABCG5 gene.

  • Sitosterolemia (246 variants)
  • Cardiovascular phenotype (218 variants)
  • not provided (166 variants)
  • Sitosterolemia 1 (80 variants)
  • Sitosterolemia 2 (69 variants)
  • not specified (49 variants)
  • Inborn genetic diseases (31 variants)
  • ABCG5-related condition (5 variants)
  • Thrombocytopenia (3 variants)
  • Sitosterolemia 2;Short-rib thoracic dysplasia 15 with polydactyly (2 variants)
  • Hyperuricemic nephropathy, familial juvenile type 4 (1 variants)
  • Abnormal bleeding;Thrombocytopenia (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ABCG5 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
12
clinvar
90
clinvar
102
missense
3
clinvar
242
clinvar
8
clinvar
1
clinvar
254
nonsense
9
clinvar
2
clinvar
11
start loss
1
clinvar
1
frameshift
5
clinvar
4
clinvar
9
inframe indel
2
clinvar
2
splice donor/acceptor (+/-2bp)
4
clinvar
5
clinvar
2
clinvar
11
splice region
11
7
18
non coding
13
clinvar
40
clinvar
34
clinvar
87
Total 18 14 272 138 35

Highest pathogenic variant AF is 0.000125

Variants in ABCG5

This is a list of pathogenic ClinVar variants found in the ABCG5 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
2-43812494-G-A Sitosterolemia 1 Benign (Jan 13, 2018)336024
2-43812495-G-A Sitosterolemia 1 Uncertain significance (Jan 12, 2018)336025
2-43812524-C-T Sitosterolemia 1 Uncertain significance (Jan 12, 2018)336026
2-43812581-G-A Sitosterolemia 1 Benign (Apr 27, 2017)894906
2-43812594-C-T Sitosterolemia 1 Benign (Jan 13, 2018)336027
2-43812605-G-T Sitosterolemia 1 Uncertain significance (Jan 13, 2018)336028
2-43812700-C-T Sitosterolemia 1 Benign (Jan 13, 2018)336029
2-43812717-G-A Sitosterolemia 1 Benign (Jan 12, 2018)336030
2-43812736-A-C Sitosterolemia 1 Benign (Apr 19, 2019)336031
2-43812758-T-TA Sitosterolemia Uncertain significance (Jun 14, 2016)336032
2-43812764-A-G Sitosterolemia 1 Uncertain significance (Jan 13, 2018)896342
2-43812831-C-G Sitosterolemia 1 Conflicting classifications of pathogenicity (Feb 01, 2023)336033
2-43812891-C-A Sitosterolemia 1 Uncertain significance (Jan 13, 2018)896343
2-43812963-G-T Sitosterolemia 1 Uncertain significance (Jan 12, 2018)896344
2-43813044-C-T Likely benign (Oct 07, 2019)1187884
2-43813120-C-T Cardiovascular phenotype Uncertain significance (Sep 26, 2022)1783259
2-43813122-G-A Uncertain significance (May 30, 2018)597409
2-43813127-T-G Cardiovascular phenotype Uncertain significance (Apr 07, 2023)2534849
2-43813130-G-A Cardiovascular phenotype Uncertain significance (Jul 13, 2023)2625955
2-43813159-C-T Sitosterolemia Uncertain significance (Jul 08, 2023)2969942
2-43813162-A-G not specified Uncertain significance (Jul 18, 2023)2577149
2-43813168-A-C Cardiovascular phenotype Uncertain significance (Jan 16, 2024)3129828
2-43813168-A-G Sitosterolemia 1 Uncertain significance (Jan 13, 2018)896345
2-43813174-G-C Cardiovascular phenotype Uncertain significance (Oct 19, 2021)1782202
2-43813181-T-A Cardiovascular phenotype Uncertain significance (Feb 26, 2023)2449162

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ABCG5protein_codingprotein_codingENST00000260645 1326394
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
3.08e-210.0010912560901391257480.000553
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.7444103701.110.00002234218
Missense in Polyphen136121.351.12071451
Synonymous-1.481791561.150.00001021349
Loss of Function-0.1333130.21.030.00000176333

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0008040.000803
Ashkenazi Jewish0.000.00
East Asian0.002230.00223
Finnish0.0001390.000139
European (Non-Finnish)0.0003710.000369
Middle Eastern0.002230.00223
South Asian0.0009810.000980
Other0.0003270.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: ABCG5 and ABCG8 form an obligate heterodimer that mediates Mg(2+)- and ATP-dependent sterol transport across the cell membrane (PubMed:27144356). Plays an essential role in the selective transport of dietary plant sterols and cholesterol in and out of the enterocytes and in the selective sterol excretion by the liver into bile (PubMed:11099417, PubMed:11138003, PubMed:27144356, PubMed:15054092). Required for normal sterol homeostasis (PubMed:11099417, PubMed:11138003, PubMed:15054092). The heterodimer with ABCG8 has ATPase activity (PubMed:16893193, PubMed:20210363, PubMed:27144356). {ECO:0000269|PubMed:11138003, ECO:0000269|PubMed:15054092, ECO:0000269|PubMed:16893193, ECO:0000269|PubMed:20210363, ECO:0000269|PubMed:27144356, ECO:0000303|PubMed:11590207, ECO:0000305|PubMed:11099417}.;
Disease
DISEASE: Sitosterolemia (STSL) [MIM:210250]: Rare autosomal recessive disorder characterized by increased intestinal absorption of all sterols including cholesterol, plant and shellfish sterols, and decreased biliary excretion of dietary sterols into bile. Sitosterolemia patients have hypercholesterolemia, very high levels of plant sterols in the plasma, and frequently develop tendon and tuberous xanthomas, accelerated atherosclerosis and premature coronary artery disease. {ECO:0000269|PubMed:11138003, ECO:0000269|PubMed:11452359, ECO:0000269|PubMed:11668628, ECO:0000269|PubMed:15054092}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Fat digestion and absorption - Homo sapiens (human);Bile secretion - Homo sapiens (human);ABC transporters - Homo sapiens (human);Cholesterol metabolism - Homo sapiens (human);Statin Pathway, Pharmacodynamics;Liver X Receptor Pathway;Nuclear Receptors Meta-Pathway;Nuclear Receptors in Lipid Metabolism and Toxicity;Angiopoietin Like Protein 8 Regulatory Pathway;Liver steatosis AOP;Statin Pathway;Vitamin A and Carotenoid Metabolism;ABC transporters in lipid homeostasis;Transport of small molecules;C21-steroid hormone biosynthesis and metabolism;ABC-family proteins mediated transport (Consensus)

Recessive Scores

pRec
0.0867

Intolerance Scores

loftool
0.359
rvis_EVS
1.16
rvis_percentile_EVS
92.65

Haploinsufficiency Scores

pHI
0.103
hipred
N
hipred_score
0.261
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.664

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Abcg5
Phenotype
muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; digestive/alimentary phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype;

Gene ontology

Biological process
drug transmembrane transport;response to nutrient;excretion;response to ionizing radiation;negative regulation of intestinal phytosterol absorption;intestinal cholesterol absorption;cholesterol efflux;cholesterol homeostasis;negative regulation of intestinal cholesterol absorption;transmembrane transport
Cellular component
plasma membrane;integral component of plasma membrane;apical plasma membrane;ATP-binding cassette (ABC) transporter complex;receptor complex
Molecular function
protein binding;ATP binding;ATPase activity;cholesterol transporter activity;ATPase activity, coupled to transmembrane movement of substances;metal ion binding;protein heterodimerization activity